Most frequent grade 3 or higher adverse events
| Event . | No. (%) of patients . |
|---|---|
| Thrombocytopenia | 22 (67) |
| Anemia | 18 (55) |
| Leukopenia | 14 (42) |
| Neutropenic infection | 14 (42) |
| Neutropenia | 11 (33) |
| Neutropenic fever | 9 (33) |
| Fatigue | 5 (15) |
| Hypoxia | 5 (15) |
| Hyponatremia | 4 (12) |
| Event . | No. (%) of patients . |
|---|---|
| Thrombocytopenia | 22 (67) |
| Anemia | 18 (55) |
| Leukopenia | 14 (42) |
| Neutropenic infection | 14 (42) |
| Neutropenia | 11 (33) |
| Neutropenic fever | 9 (33) |
| Fatigue | 5 (15) |
| Hypoxia | 5 (15) |
| Hyponatremia | 4 (12) |
The most frequent adverse events occurred in > 10% of patients, regardless of attribution to lenalidomide.